Pfizer (PFE) wins Metsera (MTSR) buyout after a heated bidding war with Novo Nordisk (NVO), securing a $10B deal for the ...

By Rishabh Jaiswal, Sabrina Valle and Maggie Fick NEW YORK/LONDON (Reuters) -U.S. drugmaker Pfizer has clinched a $10 billion ...

By Rishabh Jaiswal and Sabrina Valle (Reuters) -Obesity drug developer Metsera has accepted Pfizer's $10 billion acquisition ...

The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker ...

Pfizer Inc. has agreed to acquire weight-loss drug startup Metsera Inc. for $10 billion. The deal is an outcome of a ...

Metsera, an obesity drug developer, has accepted a $10 billion acquisition bid from Pfizer, potentially concluding a bidding ...

Pfizer has won the bidding war against Novo Nordisk to acquire obesity-drug biotech Metsera. The pharma giant upped its offer ...

Pfizer Inc. has agreed to buy Metsera Inc. for $10 billion, surpassing Novo Nordisk in a competitive bidding war. Details of ...

Pfizer has clinched a deal worth up to $10bn to buy weight-loss start-up Metsera, capping a dramatic takeover battle after ...

Pfizer will pay $86.25 a share in cash, a premium of 3.69% to Metsera's Friday close, according to Metsera's statement. The ...

Under the terms of the cash deal, Pfizer will pay $65.60 a share upfront and a contingent value right worth up to $20.65 a ...